Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "Glucosylceramidase"

ResearchPUBMEDMay 8

Rigorous genetic diagnosis review in natural history studies.

Researchers are working to improve how doctors diagnose leukodystrophies, a group of rare brain diseases that damage the white matter (the brain's communication pathways). The challenge is that many of these diseases look similar and genetic tests don't always give clear answers. A research project called the Myelin Disorders Biorepository is developing better ways to diagnose these conditions and understand how they progress over time.

WHY IT MATTERSIf you or a family member has suspected leukodystrophy but haven't received a confirmed diagnosis, this research could lead to faster, more accurate testing that helps doctors start appropriate treatment sooner.
Good to knowLeukodystrophiesMyelin disorders

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases